 |
|
|
| |
VH3810109 (N6LS) Reduces Viremia Across a Range of Doses in ART-Naive Adults Living With HIV: Proof of Concept Achieved in the Phase IIa BANNER (207959, NCT04871113) Study
|
| |
| |
Glasgow 2022 Oct 23-26
Peter Leone,1 Alejandro Ferro,2 Charlotte-Paige Rolle,3 Sergio Lupo,4 Joseph McGowan,5 Marina Klein,6 Pedro Cahn,7 Paul Benson,8 Marisa Sanchez,9 Christopher Bettacchi,10 Stefan Schneider,11 Paul Wannamaker,1 Beta Win,12 Judah Abberbock,13 Mark Baker,12 Viviana Wilches,13 Darren Bentley,14 Margaret Gartland,1 Max Lataillade,15 Jan Losos1
1ViiV Healthcare, Durham, NC, USA; 2Centro de Investigaciones Medicas, Mar del Plata, Argentina; 3Orlando Immunology Center, Orlando, FL, USA; 4CAICI, Rosario, Argentina; 5Northwell Health, New York, NY, USA; 6McGill University Health Centre, Montreal, Quebec, Canada; 7Fundacion Huesped, Buenos Aires, Argentina; 8Be Well Medical Center, Berkley, MI, USA; 9Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 10North Texas Infectious Disease Consultants, Dallas, TX, USA; 11Long Beach Education and Research Consultants, Long Beach, CA, USA; 12GSK, Brentford, UK; 13GSK, Upper Providence, PA, USA; 14Certara UK Ltd, Sheffield, UK; 15ViiV Healthcare, Branford, CT, USA
|
| |
|
|
|
|
|
